Profil bibliographique

Véronique Guerin‐Meyer

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

51Publications signalées

2121Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsCancer Treatment and PharmacologyGastric Cancer Management and OutcomesPancreatic and Hepatic Oncology Research

Publications récentes

Accès ouvert 2024 articleOpenAlex

First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA)

Jean-Louis Legoux, Roger Faroux, Nicolas M. Barrière, Karine Le Malicot et autres

2 citationsCancers

Accès ouvert 2023 articleOpenAlex

Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study

Caroline Gronnier, C. Mariette, Côme Lepage, Carole Montérymard et autres

3 citationsCancers

2023 conference-abstractOpenAlex

Assessment of an emergency 14-day (d) integrative supportive care program (14-EISCP) followed by early chemotherapy (CTx) in symptomatic patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): A prospective ARCAD cohort study.

Benoı̂t Rousseau, Antoine Falcoz, Clémence Toullec, Thierry Lecomte et autres

2 citationsJournal of Clinical Oncology

Accès ouvert 2022 articleOpenAlex

Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial

Thomas Aparicio, Olivier Bouché, Pierre-Luc Etienne, Emilie Barbier et autres

20 citationsDigestive and Liver Disease

Accès ouvert 2022 articleOpenAlex

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez, Anthony Turpin et autres

344 citationsJAMA Oncology

2022 conference-abstractOpenAlex

Aflibercept-LV5FU2 as first-line treatment of non-resectable metastatic colorectal cancers: Results of the FOLFA randomized phase II trial.

Jean-Louis Legoux, Roger Faroux, Nicolas M. Barrière, Karine Le Malicot et autres

1 citationJournal of Clinical Oncology

Accès ouvert 2021 articleOpenAlex

A Phase I dose escalation trial using Intensity-Modulated Radiotherapy with simultaneous integrated boost in Pelvic Chemoradiotherapy for Metastatic Rectal Cancer

T. Lizée, Valérie Seegers, J. Blanchecotte, Emmanuel Rio et autres

0 citationsJournal of Cancer Science and Clinical Therapeutics

Accès ouvert 2020 articleOpenAlex

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer

Benoist Chibaudel, Julie Henriques, Manel Rakez, Baruch Brenner et autres

19 citationsJAMA Network Open

2020 articleOpenAlex

444P PRODIGE 25 (FFCD 11-01)-FOLFA: A randomized phase II trial evaluating aflibercept associated with LV5FU2 regimen as first-line treatment of non-resectable metastatic colorectal cancers

Jean-Louis Legoux, Roger Faroux, Nicolas M. Barrière, Karine Le Malicot et autres

1 citationAnnals of Oncology

Accès ouvert 2020 articleOpenAlex

Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial

Thomas Aparicio, Jaafar Bennouna, Karine Le Malicot, Valérie Boige et autres

6 citationsBritish Journal of Cancer

Accès ouvert 2020 articleOpenAlex

Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol

Alice Boilève, Aline Maillard, Mathilde Wagner, Clarisse Dromain et autres

20 citationsBMC Cancer

2019 articleOpenAlex

Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence

Frédéric Dumont, S. Joseph, G. Lorimier, Valéria De Franco et autres

5 citationsSurgical Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.